VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹72 Cr | ₹45 Cr | ₹38 Cr | ₹36 Cr | ₹49 Cr |
What is the latest Profit Before Tax of VENUS REMEDIES ?
| Year | Profit Before Tax |
|---|---|
| Mar2025 | ₹72 Cr |
| Mar2024 | ₹45 Cr |
| Mar2023 | ₹38 Cr |
| Mar2022 | ₹36 Cr |
| Mar2021 | ₹49 Cr |
How is Profit Before Tax of VENUS REMEDIES Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹72 Cr | 60.89 | |
| Mar2024 | ₹45 Cr | 17.70 | |
| Mar2023 | ₹38 Cr | 4.18 | |
| Mar2022 | ₹36 Cr | -25.01 | |
| Mar2021 | ₹49 Cr | - | |
Compare Profit Before Tax of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,719.0 Cr | 18.5% | 40.9% | 244.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,096.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,807.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,718.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,971.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,752.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 18.5% |
40.9% |
244.3% |
| SENSEX | -0.5% |
-3.3% |
-7.6% |
You may also like the below Video Courses